Phenotypic Characterization of Paclitaxel-Induced Peripheral Neuropathy In Cancer Survivors

While paclitaxel is one of the most commonly used drugs to treat breast, ovarian, and lung cancers, little is known about the impact of paclitaxel-induced peripheral neuropathy (PIPN) on cancer survivors.

Source: Journal of Pain and Symptom Management - August 29, 2018 Category: Palliative Care Authors: Kord M. Kober, Melissa Mazor, Gary Abrams, Adam Olshen, Yvette P. Conley, Marilyn Hammer, Mark Schumacher, Margaret Chesney, Betty Smoot, Judy Mastick, Steven M. Paul, Jon D. Levine, Christine Miaskowski Tags: Original Article Source Type: research